Stefan Beyer, PhD, President and Managing Director recently sat down with Lab Manager to discuss ongoing expansion of Vibalogics’ Cuxhaven, Germany facility supporting our CDMO offering for oncolytic viruses, viral vector gene therapy and vaccine products.
To read the Lab Manager article: https://www.labmanager.com/lab-design-and-furnishings/virotherapy-gmp-site-expands-to-enhance-flexibility-26881
